{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:56:32Z","timestamp":1784948192778,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000095","name":"Savoy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Abnormalities in the expression of metabotropic glutamate receptor type 5 (mGluR5) have been observed in the hippocampus of patients with drug-resistant mesial Temporal Lobe Epilepsy (mTLE). <jats:italic>Ex-vivo<\/jats:italic> studies in mTLE hippocampal surgical specimens have shown increased mGluR5 immunoreactivity, while <jats:italic>in vivo<\/jats:italic> whole brain imaging using positron emission tomography (PET) demonstrated reduced hippocampal mGluR5 availability. To further understand mGluR5 abnormalities in mTLE, we performed a saturation autoradiography study with [<jats:sup>3<\/jats:sup>H]ABP688 (a negative mGluR5 allosteric modulator). We aimed to evaluate receptor density (B<jats:sub>max<\/jats:sub>) and dissociation constants (K<jats:sub>D<\/jats:sub>) in hippocampal mTLE surgical specimens and in non-epilepsy hippocampi from necropsy controls. mTLE specimens showed a 43.4% reduction in receptor density compared to control hippocampi, which was independent of age, sex and K<jats:sub>D<\/jats:sub> (multiple linear regression analysis). There was no significant difference in K<jats:sub>D<\/jats:sub> between the groups, which suggests that the decreased mGluR5 availability found <jats:italic>in vivo<\/jats:italic> with PET cannot be attributed to reduced affinity between ligand and binding site. The present study supports that changes within the epileptogenic tissue include mGluR5 internalization or conformational changes that reduce [<jats:sup>3<\/jats:sup>H]ABP688 binding, as previously suggested in mTLE patients studied <jats:italic>in vivo<\/jats:italic>.<\/jats:p>","DOI":"10.3389\/fneur.2022.888479","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T16:32:55Z","timestamp":1658507575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An in vitro Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Maria","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Minuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Aliaga Aliaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Guiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Soucy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gassan","family":"Massarweh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"El Mestikawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nn.3947","article-title":"Molecular mechanisms of epilepsy","volume":"18","author":"Staley","year":"2015","journal-title":"Nat Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"a022426","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harbor Perspect Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/107385840100700410","article-title":"Mesial temporal lobe epilepsy: what have we learned?","volume":"7","author":"Engel","year":"2001","journal-title":"Neuroscientist."},{"key":"B4","first-page":"3","article-title":"A definition of intractable epilepsy","volume":"16","author":"Sinha","year":"2011","journal-title":"Neurosci J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1535-7511.2005.05311.x","article-title":"How to explain multidrug resistance in epilepsy?","volume":"5","author":"L\u00f6scher","year":"2005","journal-title":"Epilepsy Curr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00189","article-title":"Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases","author":"Wang","year":"2012","journal-title":"Front Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0165-0173(98)00050-2","article-title":"Metabotropic glutamate receptors: electrophysiological properties and role in plasticity","volume":"29","author":"Anwyl","year":"1999","journal-title":"Brain Res Brain Res Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1152\/jn.00723.2001","article-title":"Postsynaptic induction and presynaptic expression of group 1 mGluR-dependent LTD in the hippocampal CA1 region","volume":"87","author":"Watabe","year":"2002","journal-title":"J Neurophysiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1212\/01.wnl.0000306315.03021.2a","article-title":"Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease","volume":"70","author":"Benarroch","year":"2008","journal-title":"Neurology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1152\/jn.00579.2001","article-title":"Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts","volume":"87","author":"Merlin","year":"2002","journal-title":"J Neurophysiol."},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199746545.003.0011","article-title":"Glutamate Receptors in Epilepsy: Group I mGluR-Mediated Epileptogenesis","volume-title":"Jasper's Basic Mechanisms of the Epilepsies","author":"Bianchi","year":"2012"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/hipo.22160","article-title":"Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis","volume":"23","author":"Kandratavicius","year":"2013","journal-title":"Hippocampus."},{"key":"B14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/brain\/awh673","article-title":"Up-regulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients","volume":"129","author":"Notenboom","year":"2006","journal-title":"Brain."},{"key":"B15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1023\/A:1015065626262","article-title":"Expression of the group I metabotropic glutamate receptor in the hippocampus of patients with mesial temporal lobe epilepsy","volume":"30","author":"Tang","year":"2002","journal-title":"J Neurocytol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.eplepsyres.2012.04.011","article-title":"Pilocarpine-induced status epilepticus increases Homer1a and changes mGluR5 expression","volume":"101","author":"Cavarsan","year":"2012","journal-title":"Epilepsy Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7696","DOI":"10.1523\/JNEUROSCI.4572-06.2007","article-title":"Loss of metabotropic glutamate receptor-dependent long-term depression via downregulation of mGluR5 after status epilepticus","volume":"27","author":"Kirschstein","year":"2007","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ana.25404","article-title":"In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy","volume":"85","author":"Lam","year":"2019","journal-title":"Ann Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e92765","DOI":"10.1371\/journal.pone.0092765","article-title":"In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat model","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0169-328x(96)00162-3","article-title":"Altered expression of group I metabotropic glutamate receptors in the hippocampus of amygdala-kindled rats","volume":"43","author":"Akbar","year":"1996","journal-title":"Brain Res Mol Brain Res."},{"key":"B21","first-page":"698","article-title":"Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5","volume":"47","author":"Ametamey","year":"2006","journal-title":"J Nucl Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2967\/jnumed.107.039578","article-title":"Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods","volume":"48","author":"Treyer","year":"2007","journal-title":"J. Nuclear Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.bmc.2006.10.038","article-title":"ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies","volume":"15","author":"Hintermann","year":"2007","journal-title":"Bioorgan Med Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s11064-014-1248-8","article-title":"and Br\u00e4uner-Osborne H. mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discovery","volume":"39","author":"M\u00f8lck","year":"2014","journal-title":"Neurochem Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"33750","DOI":"10.1074\/jbc.M006230200","article-title":"The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group i metabotropic glutamate receptors *","volume":"275","author":"Pagano","year":"2000","journal-title":"J. Biol. Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1093\/cercor\/bhw249","article-title":"Metabotropic glutamate receptor type 5 (mGluR5) cortical abnormalities in focal cortical dysplasia identified in vivo with [11C]ABP688 positron-emission tomography (PET) imaging","volume":"26","author":"DuBois","year":"2016","journal-title":"Cereb Cortex."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2015.00023","article-title":"Distribution of vesicular glutamate transporters in the human brain","author":"Vigneault","year":"2015","journal-title":"Front Neuroanat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/b978-0-12-407239-8.00005-7","article-title":"Immunostaining: detection of signaling protein location in tissues, cells and subcellular compartments","volume":"113","author":"Maity","year":"2013","journal-title":"Methods Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"35827","DOI":"10.1074\/jbc.M109.046276","article-title":"Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts","volume":"284","author":"Jong","year":"2009","journal-title":"J Biol. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1074\/jbc.M111.301366","article-title":"Activation of intracellular metabotropic glutamate receptor 5 in striatal neurons leads to up-regulation of genes associated with sustained synaptic transmission including Arc\/Arg31 protein *","volume":"287","author":"Kumar","year":"2012","journal-title":"J Biol Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.1038\/ncomms10604","article-title":"Intracellular mGluR5 plays a critical role in neuropathic pain","volume":"7","author":"Vincent","year":"2016","journal-title":"Nat Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1523\/jneurosci.3451-13.2014","article-title":"Intracellular mGluR5 can mediate synaptic plasticity in the hippocampus","volume":"34","author":"Purgert","year":"2014","journal-title":"J Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.bbamem.2011.11.029","article-title":"Transmembrane domains interactions within the membrane milieu: Principles, advances and challenges","volume":"1818","author":"Fink","year":"2012","journal-title":"Biochim Biophys Acta Biomembranes."},{"key":"B34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature13396","article-title":"Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain","volume":"511","author":"Dor\u00e9","year":"2014","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/jcbfm.2015.35","article-title":"Imaging in vivo glutamate fluctuations with [11 C]ABP688: a GLT-1 challenge with ceftriaxone","volume":"35","author":"Zimmer","year":"2015","journal-title":"J Cereb Blood Flow Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"16342","DOI":"10.1073\/pnas.1205838109","article-title":"Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling","volume":"109","author":"El Moustaine","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.coph.2014.12.001","article-title":"Dynamics and modulation of metabotropic glutamate receptors","volume":"20","author":"Rondard","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.biopsych.2006.12.005","article-title":"Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia","volume":"62","author":"Corti","year":"2007","journal-title":"Biol Psychiatry."},{"key":"B39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.schres.2014.06.029","article-title":"Existence of monomer and dimer forms of mGluR5, under reducing conditions in studies of postmortem brain in various psychiatric disorders","volume":"158","author":"Fatemi","year":"2014","journal-title":"Schizophrenia Res."},{"key":"B40","article-title":"Ex-vivo analysis of metabotropic glutamate receptor type 5 hippocampal abnormalities in epileptogenic foci (2021)","volume-title":"NRM 2021: XIII International Symposium of NeuroReceptor Mapping of the Living Brain","author":"Zimmermann","year":""}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.888479\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T16:33:01Z","timestamp":1658507581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.888479\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":40,"alternative-id":["10.3389\/fneur.2022.888479"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.888479","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"article-number":"888479"}}